October 17, 2011

Honeywell’s Genetron Performax® LT Approved by Emerson for use with Copeland Discus Compressors for Retrofits

MORRIS TOWNSHIP, N.J., Oct. 17, 2011 — Honeywell (NYSE: HON) today announced that its Genetron Performax® LT (R-407F) refrigerant has been approved by Emerson Climate Technologies as a retrofit solution for supermarkets and single/multi compressor refrigeration applications using its Copeland® Discus® compressors with R-22. Liquid injection is required to keep the compressor running cool in low temperature systems.

Copeland compressors are some of the most widely used in supermarket refrigeration, and approval from Emerson demonstrates Performax LT’s performance as a superior retrofit solution.

“Supermarkets invest in high-quality compressors like Emerson’s so their chillers and freezers can maintain a consistent cold temperature. Refrigeration managers want to use the most cost-effective and energy-efficient refrigerant in their compressors and, with Emerson’s approval, now they can,” said Ron Vogl, technical marketing manager for the refrigerants business of Honeywell Fluorine Products. “Performax LT preserves superheat more effectively than R-407A, R-427A, MO-99 and R-422B. Preserving superheat prevents floodback issues, which protects expensive compressors.”

Performax LT refrigerant is specifically designed to replace R-22, an ozone-depleting hydrochlorofluorocarbon (HCFC) that is being phased out under the Montreal Protocol. It can be utilized in R-22 retrofits as well as in new supermarket installations. Performax LT provides similar performance to R-22, but requires fewer equipment modifications, has lower global warming potential (GWP), and offers improved capacity and efficiency versus most popular low- and medium-temperature refrigerants. The combination of these factors provides for the lowest total CO2 footprint with a non-ozone-depleting refrigerant. Performax LT is also being utilized as an R-404A retrofit refrigerant providing similar capacity and improved efficiency while cutting GWP by almost 50%.

Performax LT, which is manufactured at Honeywell’s refrigerant facility in Louisiana, is available through Honeywell Genetron wholesale suppliers. For more information about Performax LT, visit www.genetronperformaxlt.com.

Honeywell’s Fluorine Products business is a leader in the manufacture and supply of zero ozone-depleting refrigerants used by top air-conditioning and refrigeration makers worldwide and blowing agents for energy-efficient foam insulation, as well as hydrofluoric acid and precursors for nuclear fuel.

Emerson Climate Technologies, a business unit of Emerson, is the world’s leading provider of heating, air conditioning and refrigeration solutions for residential, industrial and commercial applications. The group combines best-in-class technology with proven engineering, design, distribution, educational and monitoring services to provide customized, integrated climate-control solutions for customers worldwide. Emerson Climate Technologies’ innovative solutions, which include industry-leading brands such as Copeland Scroll and White-Rodgers, improve human comfort, safeguard food and protect the environment. For more information, visit EmersonClimate.com

Honeywell Specialty Materials is a global leader in providing customers with high-performance specialty materials, including fluorine products; specialty films and additives; advanced fibers and composites; intermediates; specialty chemicals; electronic materials and chemicals; and technologies and materials for petroleum refining.

Honeywell International (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements.

# # #